POM
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B of -0.04 suggests the company's liabilities exceed its assets.
- Low P/S ratio
- Negative Book Value
- No Graham Number available due to lack of earnings/equity
Revenue growth is insufficient to offset operational losses.
- Modest revenue growth
- Growth is far below sector average (16.2% vs 124.5%)
- Negative profit margins
Consistent long-term value destruction.
- 90.5% decline over 1, 3, and 5 years
- Extreme volatility
Critical failure in liquidity and operational efficiency.
- Piotroski F-Score 3/9
- Quick Ratio 0.09
- ROA -32.56%
Company is in no position to return capital.
- No dividend payments
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for POM and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
POM
Pomdoctor Limited
Primary
|
-90.5% | -90.5% | -90.5% | -91.4% | -7.3% | +17.2% |
|
ONMD
OneMedNet Corporation
Peer
|
-91.1% | -91.8% | +65.5% | -68.2% | +9.7% | +2.6% |
|
IMMP
Immutep Limited
Peer
|
-91.1% | -80.6% | -78.0% | -84.6% | -88.8% | -13.9% |
|
ALGS
Aligos Therapeutics, Inc.
Peer
|
-98.8% | -77.7% | -26.4% | -25.8% | +1.5% | +8.4% |
|
ARAY
Accuray Incorporated
Peer
|
-93.2% | -87.0% | -78.7% | -76.4% | -27.4% | -24.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2024
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
POM
Pomdoctor Limited
|
BEARISH | $45.43M | - | -% | -40.6% | $0.38 | |
|
ONMD
OneMedNet Corporation
|
BEARISH | $46.04M | - | -% | -206.1% | $0.88 | Compare |
|
IMMP
Immutep Limited
|
BEARISH | $46.14M | - | -61.8% | -% | $0.31 | Compare |
|
ALGS
Aligos Therapeutics, Inc.
|
BEARISH | $46.58M | - | -196.9% | -% | $7.57 | Compare |
|
ARAY
Accuray Incorporated
|
BEARISH | $44.0M | - | -70.3% | -8.2% | $0.37 | Compare |
Past News Coverage
Recent headlines mentioning POM from our newsroom.